She's admitting she has issues, that not every breakup can be squarely blamed on one person
In the crowded currents of the modern pop chart, where dominance is measured in fractions of attention, Olivia Rodrigo's second single 'The Cure' has arrived at No. 5 on the Hot 100 — not as a concession to commercial formula, but as a deliberate step toward artistic depth. The song, slow-burning and Cure-inflected, outperforms her own historical precedent despite a chart landscape flooded by Drake's three-album release and Ella Langley's crossover momentum. It is the kind of debut that asks a quieter question than most chart stories do: not merely how many people listened, but how many were willing to follow an artist into more difficult emotional terrain.
- A five-minute indie-rock track with no obvious radio hook just landed in the top five of the most competitive chart in music — and that tension between artistic risk and commercial result is the whole story.
- Drake's simultaneous three-album release and Ella Langley's chart dominance created one of the most congested Hot 100 environments in recent memory, making every position harder to claim.
- Rodrigo's previous second singles debuted at No. 8 and No. 10 respectively, so a No. 5 arrival signals that her audience is growing, not plateauing, even as she moves toward darker material.
- The album's two-part structure — euphoric love on one side, unraveling on the other — positions 'The Cure' as the emotional hinge, and its chart performance suggests listeners are willing to cross that threshold with her.
- With the full album just days away, the rollout is building rather than cooling, and the question now is whether the audience that followed her to No. 1 will stay for the more complex half of the story.
Olivia Rodrigo's 'The Cure' debuted at No. 5 on the Hot 100 this week — a strong showing made more remarkable by the conditions surrounding it. Drake flooded the upper chart with three simultaneous album releases, and Ella Langley's 'Choosin' Texas' continued its own steady climb through the top ten. Against that backdrop, a five-minute, slow-building indie-rock track landing in the top five reads less like a near-miss and more like a statement.
The song marks Rodrigo's third leader on the Hot Rock & Alternative Songs chart, following 'Brutal' and 'Bad Idea Right?' — and it outperforms both of her previous second singles, which debuted at No. 8 and No. 10 in their respective album cycles. The momentum, in other words, is moving in the right direction.
What makes 'The Cure' interesting beyond its chart position is what it represents structurally. Her upcoming album is divided into two halves: 'girl so in love' opens with the euphoria of new romance, while 'you seem pretty sad' — the section 'The Cure' launches — turns toward something darker and more honest. The song doesn't chase the immediate hook of lead single 'Drop Dead'; instead, it asks listeners to sit with the messier emotional reality of love: the unraveling, the shared blame, the uncomfortable possibility that you are part of the problem.
Rodrigo has called it one of her favorite songs she's ever written, and there's a visible tension between that personal investment and the commercial calculus of a chart debut. A No. 5 is objectively strong. It is also, perhaps, slightly below what the momentum of 'Drop Dead' might have suggested. But the Cure-influenced production and the song's unhurried runtime signal an artist willing to trust her audience's patience rather than flatter their expectations.
With the full album arriving June 12, the rollout still has room to build. The question the release will answer is whether the audience that followed her to No. 1 is ready to follow her somewhere more difficult — and whether that willingness, if it comes, will show up in the numbers.
Olivia Rodrigo's second single arrived on the Hot 100 this week at No. 5, a respectable showing that arrives amid one of the most crowded chart moments in recent memory. "The Cure," which drops June 6 on the weekly chart, follows her lead single "Drop Dead"—which debuted at the top spot in early May—and precedes the full album You Seem Pretty Sad for a Girl So in Love by just six days.
The song itself is an unusual choice for a second single. At over five minutes, it's a slow-building indie-rock track that sounds less like a radio bid and more like a statement of artistic direction. It debuted atop the Hot Rock & Alternative Songs chart, marking Rodrigo's third leader on that tally after "Brutal" in 2021 and "Bad Idea Right?" in 2023. The No. 5 debut comes as Drake released three full albums simultaneously, flooding the upper reaches of the chart, while Ella Langley's "Choosin' Texas" continues its own steady climb through the top ten.
For context on what this performance actually means: Rodrigo's second singles from her previous two albums debuted considerably lower. "Deja vu" from SOUR entered at No. 8, while "Bad Idea Right?" from GUTS came in at No. 10. By that measure, "The Cure" represents a meaningful improvement, suggesting the album rollout is building momentum rather than losing it. The chart circumstances this week are genuinely brutal—Drake's three-album deluge and Langley's crossover dominance create conditions that would have likely pushed "The Cure" even higher in a less congested week. Yet it still landed in the top five, which Billboard's editorial staff largely interpreted as a win.
The album's architecture reveals why "The Cure" matters beyond its chart position. You Seem Pretty Sad for a Girl So in Love is divided into two distinct halves: "girl so in love" and "you seem pretty sad." "Drop Dead" opens the first section with something closer to a traditional Rodrigo earworm. "The Cure" launches the second half, and its darker, more introspective tone signals a shift in emotional terrain. The song explores the messier reality of love—not the euphoria of new romance, but the ways affection can unravel you, the complexity of shared blame in a breakup, the possibility that you yourself are part of the problem.
Rodrigo has described "The Cure" as one of her favorite songs she's ever made, which raises an interesting question about artistic intention versus commercial expectation. A No. 5 debut is objectively strong, yet there's an implicit acknowledgment among observers that she might have hoped for higher. The song's Cure-influenced production and its five-minute runtime make it a riskier single choice than the immediate hooks of "Drop Dead." It's the kind of track that suggests an artist willing to trust her audience's patience, to assume they'll sit with something that doesn't immediately grab but rather slowly embeds itself.
With two weeks until release, the rollout still has room to build. The album's two-part structure has already drawn speculation about how Rodrigo might lean into that duality in her promotional campaign. Some observers wonder whether she'll lean into the personal narrative—unconfirmed reports of a breakup with actor Louis Partridge have circulated, and the album's emotional arc seems to track that possibility. Others simply want to see her continue doing what's working: letting the music speak, trusting that the songwriting will carry the conversation.
What emerges from "The Cure's" debut is a picture of an artist at a pivot point. She's proven she can still command the chart's highest real estate. Now she's demonstrating she can also ask her audience to follow her into darker, more textured territory. The question the album's release will answer is whether that audience is ready to go there with her.
Notable Quotes
The phenomenon of the tortured artist exists for good reason. Sure, being blissfully in love is cool and all, but try telling me that message hits harder in music than unleashing a full-throated 'I'm unraveled!' at the sky during a powerhouse bridge.— Billboard staff member on preference for the album's sadder second half
She's admitting she has issues, that not every breakup can be squarely blamed on one person, and she's thus finding new layers of how to address the experience of being in, and losing, love.— Billboard staff member on the album's emotional complexity
The Hearth Conversation Another angle on the story
A No. 5 debut for a second single—is that genuinely good news, or are we being generous because the chart was so crowded?
It's genuinely good news, but the context matters enormously. Her second singles used to debut at 8 and 10. This is a clear step up. The crowding actually makes it more impressive, not less.
So the Drake situation helped her, not hurt her?
It's more complicated. Drake's three albums absolutely clogged the top ten. In a normal week, "The Cure" probably debuts at 2 or 3. But the fact that it still cracked the top five despite that chaos—that tells you the song has real pull.
Why would she release something this dark as a second single? That seems risky.
Because it's not a bid for radio play. It's a statement about who she is now. She's saying: I'm not just the girl who writes earworms about heartbreak. I'm someone who can sit with complexity, with five-minute journeys, with '90s rock textures.
Does the album's two-part structure actually matter to listeners, or is that just marketing?
It matters if the songs deliver on it. "Drop Dead" and "The Cure" already signal two different emotional spaces. If the rest of the album sustains that—if the first half really does feel like love and the second half feels like its aftermath—then listeners will feel the architecture.
What's the biggest risk she's taking with this album?
Asking people to follow her away from what made her famous. Her breakthrough was a confessional ballad. This album seems to be saying she's grown past that, that she wants to explore darker, more ambiguous emotional territory. That's not a guaranteed move.
And if it works?
Then she's not just a pop star. She's an artist with real range, real depth. She becomes someone people listen to for the writing, not just the hooks.